These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 988964)

  • 41. The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.
    Tjandramaga TB; Verbeeck R; Thomas J; Verbesselt R; Verberckmoes R; Schepper PJ
    Br J Clin Pharmacol; 1976 Apr; 3(2):259-65. PubMed ID: 973960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of sotalol in twenty patients with cardiac arrhythmias.
    Latour Y; Dumont G; Brosseau A; LeLorier J
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):275-8. PubMed ID: 881280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Developing a safe intravenous sotalol dosing regimen.
    Somberg JC; Preston RA; Ranade V; Molnar J
    Am J Ther; 2010; 17(4):365-72. PubMed ID: 20562595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacokinetic study of sotalol administered intravenously to healthy men. Application of high performance liquid chromatography (author's transl)].
    Poirier JM; Aubry JP; Cheymol G; Jaillon P
    Therapie; 1981; 36(4):465-71. PubMed ID: 7292430
    [No Abstract]   [Full Text] [Related]  

  • 45. Sotalol: another beta adrenergic blocking agent?
    Ahlquist RP
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):495-6. PubMed ID: 489768
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical pharmacokinetics of sotalol.
    Hanyok JJ
    Am J Cardiol; 1993 Aug; 72(4):19A-26A. PubMed ID: 8346722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pharmacokinetics of propylthiouracil.
    Kampmann J; Skovsted L
    Acta Pharmacol Toxicol (Copenh); 1974 Nov; 35(5):361-9. PubMed ID: 4479714
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparative beta-adrenoceptor blocking effects and pharmacokinetics of sotalol and propranolol in healthy volunteers].
    Richer C; Maury M; Poirier JM; Duhaze P; Giudicelli JF
    Therapie; 1982; 37(3):259-67. PubMed ID: 6753226
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of the effects of chronic oral therapy with atenolol and sotalol on ventricular monophasic action potential duration and effective refractory period.
    Way BP; Forfar JC; Cobbe SM
    Am Heart J; 1988 Sep; 116(3):740-6. PubMed ID: 3046277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxygen uptake kinetics and cardiopulmonary performance in lone atrial fibrillation and the effects of sotalol.
    Lok NS; Lau CP
    Chest; 1997 Apr; 111(4):934-40. PubMed ID: 9106572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
    Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A pharmacokinetic-pharmacodynamic model of d-sotalol Q-Tc prolongation during intravenous administration to healthy subjects.
    Salazar DE; Much DR; Nichola PS; Seibold JR; Shindler D; Slugg PH
    J Clin Pharmacol; 1997 Sep; 37(9):799-809. PubMed ID: 9549633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multicenter trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol Multicenter Study Group.
    Singh BN; Kehoe R; Woosley RL; Scheinman M; Quart B
    Am Heart J; 1995 Jan; 129(1):87-97. PubMed ID: 7817931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and protein binding of prednisolone after oral and intravenous administration.
    Bergrem H; Grøttum P; Rugstad HE
    Eur J Clin Pharmacol; 1983; 24(3):415-9. PubMed ID: 6861855
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacokinetics and pharmacodynamics of the beta-receptor blocker sotalol].
    Limbourg P; Just H; Kersting F; Lang KF
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1690-4. PubMed ID: 347795
    [No Abstract]   [Full Text] [Related]  

  • 56. Sotalol intoxication, two patients with concentration-effect relationships.
    Neuvonen PJ; Elonen E; Tarssanen L
    Acta Pharmacol Toxicol (Copenh); 1979 Jul; 45(1):52-7. PubMed ID: 474159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and bioavailability of hydromorphone following intravenous and oral administration to human subjects.
    Vallner JJ; Stewart JT; Kotzan JA; Kirsten EB; Honigberg IL
    J Clin Pharmacol; 1981 Apr; 21(4):152-6. PubMed ID: 6165742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of antipyrine in epileptic patients.
    Rimmer EM; Routledge PA; Tsanaclis LM; Richens A
    Br J Clin Pharmacol; 1986 May; 21(5):511-4. PubMed ID: 3718808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bioequivalence of a new tablet formulation of sotalol hydrochloride in comparison to a standard preparations].
    Herrmann R; Kleinbloesem CH
    Arzneimittelforschung; 1994 May; 44(5):589-92. PubMed ID: 8024627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of intravenously and orally administered sotalol hydrochloride in horses and effects on surface electrocardiogram and left ventricular systolic function.
    Broux B; De Clercq D; Decloedt A; De Baere S; Devreese M; Van Der Vekens N; Ven S; Croubels S; van Loon G
    Vet J; 2016 Feb; 208():60-4. PubMed ID: 26670333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.